Effect of level of presentation to listeners on scaled speech intelligibility of speakers with dysarthria

Folia Phoniatrica et Logopaedica

Volumn 64, Issue 1, 2011, Pages 26-33

  Kim, Yunjung ^a   Kuo, Christina ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Dysarthria; Presentation level; Speech intelligibility

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; DYSARTHRIA; HEARING; HUMAN; OBSERVER VARIATION; PARKINSON DISEASE; PSYCHOLOGICAL ASPECT; SHY DRAGER SYNDROME; SPEECH INTELLIGIBILITY; STROKE; VOICE;

ADULT; DYSARTHRIA; HUMANS; LOUDNESS PERCEPTION; MULTIPLE SYSTEM ATROPHY; OBSERVER VARIATION; PARKINSON DISEASE; SPEECH INTELLIGIBILITY; STROKE; VOICE QUALITY; YOUNG ADULT;

EID: 84055200050     PISSN: 10217762     EISSN: None     Source Type: Journal    
DOI: 10.1159/000328642     Document Type: Article

References (36)

1. Pollack I: Effects of high pass and low pass filtering on the intelligibility of speech in noise. J Acoust Soc Am 1948; 20: 259-266.
2. Kent RD, Wiley TL, Strennen ML: Consonant discrimination as a function of presentation level. Audiology 1979; 18: 212-224. (Pubitemid 9178065)
3. Darley FL, Aronson AE, Brown JR: Differential diagnostic patterns of dysarthria. J Speech Hear Res 1969; 12: 246-269.
4. Darley FL, Aronson AE, Brown JR: Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res 1969; 12: 462-496.
5. Duffy J: Motor Speech Disorders: Substrates, Differential Diagnosis, and Management, ed 2. St Louis, Mosby, 2005.
6. Fox CM, Ramig LO, Ciucci MR, Sapir S, Mc- Farland DH, Farley BG: The science and practice of LSVT/LOUD: Neural plasticityprincipled approach to treating individuals with Parkinson disease and other neurological conditions. Semin Speech Lang 2006; 27: 283-299. (Pubitemid 44970749)
7. Cooper IS, Riklan M, Stellar S, Waltz JM, Levita E, Ribera VA, Zimmerman J: A multidisciplinary investigation of neurosurgical rehabilitation in bilateral parkinsonism. J Am Geriatr Soc 1968; 16: 1177-1306.
8. Spielman J, Ramig LO, Mahler L, Halpern A, Gavin WJ: Effects of an extended version of the Lee Silverman voice and speech in Parkinson's disease. Am J Speech Lang Pathol 2007; 16: 95-107.
9. Baumgartner CA, Sapir S, Ramig LO: Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease. J Voice 2001; 15: 105-114. (Pubitemid 32231496)
10. Dromey C, Ramig LO, Johnson AB: Phonatory articulatory changes associated with increased vocal intensity in Parkinson disease: A case study. J Speech Hear Res 1995; 38: 751-764.
11. Tjaden K, Wilding GE: Rate and loudness manipulations in dysarthria: Acoustic and perceptual findings. J Speech Lang Hear Res 2004; 47: 766-783. (Pubitemid 39129112)
12. Tripoliti E, Limousin P: Electrical stimulation of deep brain structures and speech; in Massen B, van Lieshout P (eds): Speech Motor Control: New Developments in Basic and Applied Research. Oxford, Oxford University Press, 2010, pp 297-313.
13. Tripoliti E, Limousin P, Tisch S, Borrell E, Hariz MI: Speech in Parkinson's disease following subthalamic nucleus deep brain stimulation: Preliminary results. J Med Speech Lang Pathol 2006; 14: 309-315.
14. Tripoliti E, Zinzro L, Borrell E, Frost E, Tisch S, Martinez I, Hariz M, Limousin P: Effect of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov Disord 2008; 23: 2377-2383.
15. Turner G, Martin H, de Jonge R: Influence of amplification on word intelligibility and phonetic contrast errors in dysarthria. J Med Speech Lang Pathol 2008; 16: 267-274.
16. Green MCL, Watson B: The value of speech amplification in Parkinson's disease patients. Folia Phoniatr Logop 1968; 20: 250-257.
17. Adams SG: Hypokinetic dysarthria; in Mc- Neil MR (ed): Clinical Management of Sensorimotor Speech Disorders. New York, Thieme, 1997.
18. Neel AT: Effects of loud and amplified speech on sentence and word intelligibility in Parkinson disease. J Speech Lang Hear Res 2009; 52: 1021-1033.
19. Kim YJ, Kent RD, Weismer G: An acoustic study of the relationships among neurologic disease, dysarthria type, and severity of dysarthria. J Speech Lang Hear Res 2011; 54: 417-429.
20. Weismer G, Laures JS: Direct magnitude estimates of speech intelligibility in dysarthria: Effects of a chosen standard. J Speech Lang Hear Res 2002; 45: 421-433. (Pubitemid 34596312)
21. Fahn S, Elton RL, UPDRS Development Committee: Unified Parkinson Disease Rating Scale; in Fahn S, Marsden CD, Goldstein M, Calne DB (eds): Recent Developments in Parkinson's Disease. Florham Park, Macmillan, 1987, vol 2, pp 153-163.
22. Enderby P: Frenchay dysarthria assessment. Int J Lang Commun Disord 1980; 15: 165-173. (Pubitemid 11190785)
23. Enderby P, Palmer R: FDA2: Frenchay Dysarthria Assessment. Austin, Pro-Ed, 2008.
24. Miller SE, Schlauch RS, Watson PJ: The effects of fundamental frequency contour manipulations on speech intelligibility in background noise. J Acoust Soc Am 2010; 128: 435-443.
25. Fant G, Kruckenberg A, Liljencrants J: The source-filter frame of prominence. Phonetica 2000; 57: 113-127.
26. Ramig LO, Countryman S, Thompson LL, Horii Y: Comparison of two forms of intensive speech treatment for Parkinson disease. J Speech Hear Res 1995; 38: 1232-1251.
27. Ramig, LO, Sapir S, Countryman S, Pawlas AA, O'Brien C, Hoehn M, Thompson LL: Intensive voice treatment (LSVT) for patients with Parkinson's disease: A 2 year follow up. J Neurol Neurosurg Psychiatry 2001; 71: 493-498. (Pubitemid 32906873)
28. Engen T: Psychophysics: Discrimination and detection; in Kling JW, Riggs LA (eds): Woodworth and Schlossberg's Experimental Psychology, ed 3. New York, Holt, 1971, pp 11-46.
29. Sheard C, Adams RD, Davis PJ: Reliability and agreement of ratings of ataxic dysarthric speech samples with varying intelligibility. J Speech Hear Res 1991; 34: 285-293.
30. Mahler LA, Ramig LO, Fox C: Intensive voice treatment (LSVT-LOUD) for dysarthria secondary to stroke. J Med Speech Lang Pathol 2009; 17/4.
31. Wenke RJ, Theodoros D, Cornwell P: The short-And long-term effectiveness of the LSVT for dysarthria following TBI and stroke. Brain Inj 2008; 22: 339-352. (Pubitemid 351448006)
32. Solomon NP, Makasha MJ, Kessler LS, Sullivan KW: Speech-breathing treatment and LSVT for a patient with hypokinetic-spastic dysarthria after TBI. J Med Speech Lang Pathol 2004; 10: 51-64.
33. Fox C, Boliek C, Ramig LO: The impact of intensive voice treatment (LSVT) on speech intelligibility in children with spastic cerebral palsy. Mov Disord 2005; 20:S149.
34. Sapir S, Pawlas A, Ramig LO, Seeley E, Fox C, Corboy J: Effects of intensive phonatoryrespiratory treatment (LSVT) on voice in two individuals with multiple sclerosis. J Med Speech Lang Pathol 2001; 9: 141-151. (Pubitemid 32531046)
35. Audo CMC: Applying the Lee Silverman Voice Treatment (LSVT) to the Down Syndrome Population: A Single-Subject Design; MA thesis, University of Colorado, 2004.
36. Fox C, Ramig LO: Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. Am J Speech Lang Pathol 1997; 6: 85-94.